Skip to main content

Advertisement

SpringerLink
Log in

Commentary on: “Effect of obesity on survival in women with breast cancer: systematic review and meta-analysis” (Melinda Protani, Michael Coory, Jennifer H. Martin)

  • Invited Commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

The Original Article was published on 23 June 2010

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Goodwin PJ, Esplen MJ, Winocur J, Butler K, Pritchard KI (1995) Development of a weight management program in women with newly diagnosed breast cancer. In: 11th international congress of psychosomatic obstetrics and gynecology, Basel, Switzerland

  2. Ryu SY, Kim CB, Nam CM, Park JK, Kim KS, Park J et al (2001) Is body mass index the prognostic factor in breast cancer?: a meta-analysis. J Korean Med Sci 16:610–614

    CAS  PubMed  Google Scholar 

  3. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. doi:10.1007/s10549-010-0990-0

  4. Suissa S, Pollak M, Spitzer WO, Margolese R (1989) Body size and breast cancer prognosis: a statistical explanation of the discrepancies. Cancer Res 49:3113–3116

    CAS  PubMed  Google Scholar 

  5. Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME et al (2009) High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 114:517–525

    Article  CAS  PubMed  Google Scholar 

  6. Greenman CG, Jagielski CH, Griggs JJ (2008) Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice. Cancer 112:2159–2165

    Article  CAS  PubMed  Google Scholar 

  7. Madarnas Y, Sawka CA, Franssen E, Bjarnason GA (2001) Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res Treat 66:123–133

    Article  CAS  PubMed  Google Scholar 

  8. Jenkins P, Elyan S, Freeman S (2007) Obesity is not associated with increased myelosuppression in patients receiving chemotherapy for breast cancer. Eur J Cancer 43:544–548

    Article  CAS  PubMed  Google Scholar 

  9. Cleary MP, Grossmann ME (2009) Minireview: obesity and breast cancer: the estrogen connection. Endocrinology 150:2537–2542

    Article  CAS  PubMed  Google Scholar 

  10. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120–1131

    CAS  PubMed  Google Scholar 

  11. Wysocki PJ, Wierusz-Wysocka B (2010) Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. Expert Rev Mol Diagn 10:509–519

    Article  CAS  PubMed  Google Scholar 

  12. Pollak MN, Chapman JW, Shepherd L, Meng P, Richardson C, Wilson B et al. (2006) Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA. 14 adjuvant breast cancer trial. J Clin Oncol 24(Suppl. 18S):9s (Abstr 524)

  13. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238

    Article  CAS  PubMed  Google Scholar 

  14. Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J et al (2005) Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 23:6037–6042

    Article  CAS  PubMed  Google Scholar 

  15. Ray A, Cleary MP (2010) Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets 14:443–451

    Article  CAS  PubMed  Google Scholar 

  16. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH et al (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27:3437–3444

    Article  CAS  PubMed  Google Scholar 

  17. Cole SW (2009) Chronic inflammation and breast cancer recurrence. J Clin Oncol 27:3418–3419

    Article  PubMed  Google Scholar 

  18. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY (2003) Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 88:1721–1726

    Article  CAS  PubMed  Google Scholar 

  19. Ligibel JA, Giobbie-Hurder A, Olenczuk D, Campbell N, Salinardi T, Winer EP et al (2009) Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors. Cancer Causes Control 20:1523–1528

    Article  PubMed  Google Scholar 

  20. Goodwin PJ, Pritchard KI, Ennis M, Clemons M, Graham M, Fantus IG (2008) Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 8:501–505

    Article  CAS  PubMed  Google Scholar 

  21. Sestak I, Distler W, Forbes JF, Dowsett M, Howell A, Cuzick J (2010) Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J Clin Oncol. doi:10.1200/JCO.2009.27.2021

  22. Pfeiler G, Königsberg R, Singer CF, Seifert M, Dubsky PC, Samonigg H et al. (2010) Impact of body mass index on endocrine therapy in premenopausal breast cancer: an analysis of the ABCSG-12 trial. J Clin Oncol 28(15S) (Abst 512)

  23. Goodwin PJ, Pritchard KI (2010) Obesity and hormone therapy in breast cancer: an unfinished puzzle. J Clin Oncol. doi:10.1200/JCO.2010.29.5113

  24. Rooney M, Wald A (2007) Interventions for the management of weight and body composition changes in women with breast cancer. Clin J Oncol Nurs 11:41–52

    Article  PubMed  Google Scholar 

  25. Kirshbaum MN (2007) A review of the benefits of whole body exercise during and after treatment for breast cancer. J Clin Nurs 16:104–121

    Article  PubMed  Google Scholar 

  26. Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A et al (2009) Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 101:630–643

    Article  PubMed  Google Scholar 

  27. Goodwin PJ, Ligibel JA, Stambolic V (2009) Metformin in breast cancer: time for action. J Clin Oncol 27:3271–3273

    Article  CAS  PubMed  Google Scholar 

  28. Ben Sahra I, Marchand-Brustel Y, Tanti JF, Bost F (2010) Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9:1092–1099

    Article  CAS  PubMed  Google Scholar 

  29. Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, Decensi A (2009) Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev 18:701–705

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Clinical Epidemiology at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital and Princess Margaret Hospital, University of Toronto, 1284-600 University Avenue, Toronto, Ontario, M5G 1X4, Canada

    Pamela J. Goodwin

Authors
  1. Pamela J. Goodwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pamela J. Goodwin.

Additional information

This is an invited commentary to article doi:10.1007/s10549-010-0990-0.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodwin, P.J. Commentary on: “Effect of obesity on survival in women with breast cancer: systematic review and meta-analysis” (Melinda Protani, Michael Coory, Jennifer H. Martin). Breast Cancer Res Treat 123, 637–640 (2010). https://doi.org/10.1007/s10549-010-1101-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1101-y

Keywords

Search

Navigation